|
|
||||||||
Department of Physiology, Yamaguchi University School of Medicine, Japan.
1. We investigated the central role of corticotrophin-releasing factor (CRF-41) in psychological stress-induced responses, including cardiovascular, thermoregulatory and locomotive activity in free-moving rats. 2. Psychological stress was induced by cage-switch stress. After rats were placed in the novel environment, blood pressure, heart rate, body temperature and locomotive activity significantly increased. The intracerebroventricular (I.C.V.) injection of alpha-helical CRF(9-41), a CRF-41 receptor antagonist, significantly attenuated the stress-induced hypertension, tachycardia, hyperthermia and increase in locomotive activity. However, in unstressed rats, the I.C.V. injection of alpha-helical CRF(9-41) had no effect on physiological parameters measured in this study. 3. In unstressed rats, the I.C.V. injection of CRF-41 (1 microgram and 10 micrograms) increased blood pressure, heart rate, body temperature and locomotive activity in a dose-dependent manner. The changes in these responses were quite similar to those observed during cage-switch stress. 4. The results suggest that central CRF-41 plays an important role in psychological stress-induced hypertension, hyperthermia, tachycardia and increase in locomotive activity. However, it is likely that central CRF-41 does not contribute to normal cardiovascular and body temperature regulation when rats are free from stress.
This article has been cited by other articles:
![]() |
L. Wang, G. Muxin, H. Nishida, C. Shirakawa, S. Sato, and T. Konishi Psychological Stress-Induced Oxidative Stress as a Model of Sub-Healthy Condition and the Effect of TCM Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 195 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. C. Webb, and M. W. Brands Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1394 - R1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. Leite, C. Fleming, J. S. Pollock, R. C. Webb, and M. W. Brands Hypertensive Response to Acute Stress Is Attenuated in Interleukin-6 Knockout Mice Hypertension, September 1, 2004; 44(3): 259 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Shalev, J. W. Grimm, and Y. Shaham Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review Pharmacol. Rev., March 1, 2002; 54(1): 1 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oka, K. Oka, and T. Hori Mechanisms and Mediators of Psychological Stress-Induced Rise in Core Temperature Psychosom Med, May 1, 2001; 63(3): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. W. Day, A. Badiani, J. M. Uslaner, M. M. Oates, N. M. Vittoz, T. E. Robinson, S. J. Watson Jr, and H. Akil Environmental Novelty Differentially Affects c-fos mRNA Expression Induced by Amphetamine or Cocaine in Subregions of the Bed Nucleus of the Stria Terminalis and Amygdala J. Neurosci., January 15, 2001; 21(2): 732 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okuyama, S. Chaki, N. Kawashima, Y. Suzuki, S.-I. Ogawa, A. Nakazato, T. Kumagai, T. Okubo, and K. Tomisawa Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001 J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 926 - 935. [Abstract] [Full Text] |
||||
![]() |
A. Badiani, M. M. Oates, H. E. W. Day, S. J. Watson, H. Akil, and T. E. Robinson Amphetamine-Induced Behavior, Dopamine Release, and c-fos mRNA Expression: Modulation by Environmental Novelty J. Neurosci., December 15, 1998; 18(24): 10579 - 10593. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Martínez, J. Rivier, L. Wang, and Y. Taché Central Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks CRF- and Stress-Related Alterations of Gastric and Colonic Motor Function J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 754 - 760. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |